Entrada Therapeutics
TRDA
#7463
Rank
A$0.63 B
Marketcap
A$16.57
Share price
-2.32%
Change (1 day)
-38.56%
Change (1 year)

Entrada Therapeutics (TRDA) - Total debt

Total debt on the balance sheet as of September 2025 : A$79.2 Million

According to Entrada Therapeutics's latest financial reports the company's total debt is A$79.2 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Entrada Therapeutics - Total debt on balance sheet (from 2021 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$95.18 M-4.95%
2023-12-31A$0.10 B162.76%
2022-12-31A$38.11 M
2021-12-31N/A